Identification of the cystic fibrosis gene: genetic analysis, Science, vol.245, issue.4922, pp.1073-1080, 1989. ,
DOI : 10.1126/science.2570460
Cystic Fibrosis: What to Expect now in the Early Adult Years, Paediatric Respiratory Reviews, vol.13, issue.4, pp.206-214, 2012. ,
DOI : 10.1016/j.prrv.2012.03.005
Future Directions in Early Cystic Fibrosis Lung Disease Research, American Journal of Respiratory and Critical Care Medicine, vol.185, issue.8 ,
DOI : 10.1164/rccm.201111-2068WS
Update in Cystic Fibrosis 2012, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.9, pp.915-919, 2013. ,
DOI : 10.1164/rccm.201301-0184UP
Guide to Bone Health and Disease in Cystic Fibrosis, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.3, pp.1888-1896, 2005. ,
DOI : 10.1210/jc.2004-1629
Impact of cystic fibrosis on bone health, Current Opinion in Pulmonary Medicine, vol.16, issue.6, pp.616-622, 2010. ,
DOI : 10.1097/MCP.0b013e32833e2e94
Low Bone Mineral Density in Young Children with Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.175, issue.9, pp.951-957, 2007. ,
DOI : 10.1164/rccm.200606-776OC
???Old??? bones in young bodies: the tale of cystic fibrosis, Current Opinion in Endocrinology, Diabetes and Obesity, vol.16, issue.6, pp.407-414, 2009. ,
DOI : 10.1097/MED.0b013e3283329b16
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease, The American Journal of Medicine, vol.101, issue.3, pp.262-269, 1996. ,
DOI : 10.1016/S0002-9343(96)00155-6
A Roadmap to the Brittle Bones of Cystic Fibrosis, Journal of Osteoporosis, vol.11, issue.1, p.926045, 2010. ,
DOI : 10.1038/ncprheum0977
Prevalence and correlates of vertebral fractures in adults with cystic fibrosis, Bone, vol.35, issue.3, pp.771-776, 2004. ,
DOI : 10.1016/j.bone.2004.05.009
European cystic fibrosis bone mineralisation guidelines, Journal of Cystic Fibrosis, vol.10, issue.2, pp.10-16, 2011. ,
DOI : 10.1016/S1569-1993(11)60004-0
Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.3, pp.306-311, 2006. ,
DOI : 10.1164/rccm.200512-1943OC
Persistent Osteopenia in Adult Cystic Fibrosis Transmembrane Conductance Regulator???deficient Mice, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.3, pp.309-315, 2008. ,
DOI : 10.1164/rccm.200705-659OC
Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone Disease, PLoS ONE, vol.349, issue.11, p.80098, 2013. ,
DOI : 10.1371/journal.pone.0080098.g005
The F508del Mutation in Cystic Fibrosis Transmembrane Conductance Regulator Gene Impacts Bone Formation, The American Journal of Pathology, vol.180, issue.5, pp.2068-2075, 2012. ,
DOI : 10.1016/j.ajpath.2012.01.039
URL : https://hal.archives-ouvertes.fr/inserm-00846637
Osteopenia in Cftr-deltaF508 mice, Journal of Cystic Fibrosis, vol.9, issue.4, pp.239-245, 2011. ,
DOI : 10.1016/j.jcf.2010.05.001
Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone, Thorax, vol.62, issue.7, pp.650-651, 2007. ,
DOI : 10.1136/thx.2006.075887
Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis, European Respiratory Journal, vol.39, issue.3, pp.780-781, 2012. ,
DOI : 10.1183/09031936.00104111
URL : https://hal.archives-ouvertes.fr/inserm-00602058
24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: Follow up using brain spectroscopy, Molecular Genetics and Metabolism, vol.96, issue.2, pp.55-58, 2009. ,
DOI : 10.1016/j.ymgme.2008.10.002
URL : https://hal.archives-ouvertes.fr/hal-00805433
Effect of Miglustat on Bone Disease in Adults with Type 1 Gaucher Disease: A Pooled Analysis of Three Multinational, Open-Label Studies, Clinical Therapeutics, vol.29, issue.8, pp.1645-1654, 2007. ,
DOI : 10.1016/j.clinthera.2007.08.006
A Cystic Fibrosis Respiratory Epithelial Cell Chronically Treated by Miglustat Acquires a Non???Cystic Fibrosis???Like Phenotype, American Journal of Respiratory Cell and Molecular Biology, vol.41, issue.2, pp.217-225, 2009. ,
DOI : 10.1165/rcmb.2008-0285OC
URL : https://hal.archives-ouvertes.fr/hal-00444213
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects, Science, vol.304, issue.5670, pp.600-602, 2004. ,
DOI : 10.1126/science.1093941
Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the ??-glucosidase inhibitor miglustat, FEBS Letters, vol.5, issue.8, pp.2081-2086, 2006. ,
DOI : 10.1016/j.febslet.2006.03.010
Airway Delivery of Low-Dose Miglustat Normalizes Nasal Potential Difference in F508del Cystic Fibrosis Mice, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.11, pp.1022-1028, 2009. ,
DOI : 10.1164/rccm.200901-0049OC
A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference, Journal of Cystic Fibrosis, vol.11, issue.3, pp.231-236, 2012. ,
DOI : 10.1016/j.jcf.2011.12.004
Miglustat effects on the basal nasal potential differences in cystic fibrosis, Journal of Cystic Fibrosis, vol.12, issue.1, p.88, 2012. ,
DOI : 10.1016/j.jcf.2012.06.003
A mouse model for the cystic fibrosis delta F508 mutation, Embo J, vol.14, pp.4403-4411, 1995. ,
Impact of Nutrition on Phenotype in CFTR-deficient Mice, Pediatric Research, vol.2, issue.5, pp.528-532, 2007. ,
DOI : 10.1203/PDR.0b013e318155a61d
Biological and Medical Significance of Calcium Phosphates, Angewandte Chemie International Edition, vol.106, issue.311, pp.3130-3146, 2002. ,
DOI : 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee, Journal of Bone and Mineral Research, vol.10, issue.6, pp.595-610, 1987. ,
DOI : 10.1002/jbmr.5650020617
Restoration of Chloride Efflux by Azithromycin in Airway Epithelial Cells of Cystic Fibrosis Patients, Antimicrobial Agents and Chemotherapy, vol.55, issue.4, pp.1792-1793, 2012. ,
DOI : 10.1128/AAC.01403-10
Vitamin A supplementation for cystic fibrosis, Cochrane Database Syst Rev, vol.8, p.6751, 2012. ,
Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: Effect of supplementation with vitamin D and calcium, Pediatric Pulmonology, vol.88, issue.8, pp.772-780, 2008. ,
DOI : 10.1002/ppul.20863
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton, Endocrine Reviews, vol.29, issue.5, pp.535-559, 2008. ,
DOI : 10.1210/er.2007-0036
WNT signaling in bone homeostasis and disease: from human mutations to treatments, Nature Medicine, vol.28, issue.2, pp.179-192, 2013. ,
DOI : 10.1016/j.bone.2009.02.012
Gestational and Neonatal Characteristics of Children with Cystic Fibrosis: A Cohort Study, The Journal of Pediatrics, vol.147, issue.3, pp.316-320, 2005. ,
DOI : 10.1016/j.jpeds.2005.04.031
Insulin-like Growth Factor-I Levels Predict Weight, Height and Protein Catabolism in Children and Adolescents with Cystic Fibrosis, Journal of Pediatric Endocrinology and Metabolism, vol.22, issue.5, pp.417-424, 2009. ,
DOI : 10.1515/JPEM.2009.22.5.417
Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth, Proceedings of the National Academy of Sciences, vol.107, issue.47, pp.20571-20575, 2000. ,
DOI : 10.1073/pnas.1015281107
Histomorphometric Analysis of Bone Biopsies from the Iliac Crest of Adults with Cystic Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.11, pp.1470-1474, 1999. ,
DOI : 10.1164/rccm.200206-578OC
Reduced bone density in cystic fibrosis: ??F508 mutation is an independent risk factor, European Respiratory Journal, vol.25, issue.1, pp.54-61, 2005. ,
DOI : 10.1183/09031936.04.00050204
Minireview: Osteoprotective Action of Estrogens Is Mediated by Osteoclastic Estrogen Receptor-??, Molecular Endocrinology, vol.24, issue.5, pp.877-885, 2011. ,
DOI : 10.1210/me.2009-0238
Impaired CFTR-Dependent Amplification of FSH-Stimulated Estrogen Production in Cystic Fibrosis and PCOS, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.3, pp.923-932, 2012. ,
DOI : 10.1210/jc.2011-1363
??-Oestradiol rescues ??F508CFTR functional expression in human cystic fibrosis airway CFBE41o??? cells through the up-regulation of NHERF1, Biology of the Cell, vol.282, issue.7, pp.399-412, 2008. ,
DOI : 10.1042/BC20070095
Parallel Improvement of Sodium and Chloride Transport Defects by Miglustat (n-Butyldeoxynojyrimicin) in Cystic Fibrosis Epithelial Cells, Journal of Pharmacology and Experimental Therapeutics, vol.325, issue.3, pp.1016-1023, 2008. ,
DOI : 10.1124/jpet.107.135582
URL : https://hal.archives-ouvertes.fr/hal-00402085
N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing, J Biol Chem, vol.269, pp.27108-27114, 1994. ,
Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis, British Journal of Nutrition, vol.95, issue.06, pp.1159-1165, 2006. ,
DOI : 10.1079/BJN20061778
Fenretinide Corrects Newly Found Ceramide Deficiency in Cystic Fibrosis, American Journal of Respiratory Cell and Molecular Biology, vol.38, issue.1, pp.47-56, 2008. ,
DOI : 10.1165/rcmb.2007-0036OC
Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis, Annals of Internal Medicine, vol.128, issue.3, pp.186-193, 1998. ,
DOI : 10.7326/0003-4819-128-3-199802010-00004
The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis, Calcified Tissue International, vol.134, issue.1, pp.1-7, 2010. ,
DOI : 10.1007/s00223-009-9316-9
Bisphosphonate-Induced Osteopetrosis: Novel Bone Modeling Defects, Metaphyseal Osteopenia, and Osteosclerosis Fractures After Drug Exposure Ceases, Journal of Bone and Mineral Research, vol.92, issue.S1, pp.1698-1707, 2008. ,
DOI : 10.1359/jbmr.080511
The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat, Xenobiotica, vol.358, issue.3, pp.298-314, 2007. ,
DOI : 10.1016/S0140-6736(00)02161-9
Miglustat as a therapeutic agent: prospects and caveats, Journal of Medical Genetics, vol.49, issue.9, pp.591-597, 2012. ,
DOI : 10.1136/jmedgenet-2012-101070